Cardiology

Canagliflozin may reduce the risk of major cardiovascular complication, but amputation risk is increased.

Among long-term users, discontinuation of low-dose aspirin in absence of surgery or bleeding had a greater than 30% increased risk of cardiovascular events.

Intensive control of blood pressure, glucose, and lipids benefits patients with type 2 diabetes, the long-awaited, large Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular Diseases (J-DOIT3).

New study finds lower occurrence of heart failure in older people with type 2.

The pendulum has swung from too much fat to too many carbs.

Even though screening the general population does not impact mortality or CVD incidence, it did have benefits for those diagnosed with diabetes.

Updated blood pressure control numbers may have cardiovascular benefits for some patients.

Treatment of hypoglycemia contributes to ASCVD risk reduction.

Carotid ultrasound shows atherosclerotic disease is not just a concern for patients with type 1 and type 2 diabetes, but LADA as well.

Research suggests screening for latent coronary artery disease to decrease complications.